Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Top Cited Papers
Open Access
- 3 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 14 (6), 790-797
- https://doi.org/10.1093/neuonc/nos076
Abstract
Optic pathway gliomas (OPGs) occur in 15%–20% of children with neurofibromatosis type 1 (NF1); up to half become symptomatic. There is little information regarding ophthalmologic outcomes after chemotherapy. A retrospective multicenter study was undertaken to evaluate visual outcomes following chemotherapy for NF1-associated OPG, to identify risks for visual loss, and to ascertain indications for treatment. Subjects included children undergoing initial treatment for OPGs with chemotherapy between January 1997 and December 2007. Of 115 subjects, visual acuity (VA) decline and tumor progression were the primary reasons to initiate treatment, although there were significant differences in the pattern of indications cited among the institutions. Eighty-eight subjects and 168 eyes were evaluable for VA outcome. At completion of chemotherapy, VA improved (32% of subjects), remained stable (40%), or declined (28%). Tumor location was the most consistent prognostic factor for poor VA outcome. There was poor correlation between radiographic and VA outcomes. Although visual outcomes for NF1-associated OPG are not optimal, approximately one-third of children regain some vision with treatment. Since radiographic outcomes do not predict visual outcomes, their use as the primary measure of treatment success is in question. The lack of consensus regarding the indications for treatment underlines the need for better standardization of care. Future clinical trials for OPG require standardized visual assessment methods and clear definitions of visual outcomes.This publication has 32 references indexed in Scilit:
- Retinal Nerve Fiber Layer Thickness in Children With Optic Pathway GliomasAmerican Journal of Ophthalmology, 2011
- Optic pathway glioma: Long-term visual outcome in children without neurofibromatosis type-1Pediatric Blood & Cancer, 2010
- Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology programNeuro-Oncology, 2007
- Prognostic factors for progression of childhood optic pathway glioma: A systematic reviewEuropean Journal of Cancer, 2006
- Progression-Free Survival in Children With Optic Pathway Tumors: Dependence on Age and the Quality of the Response to Chemotherapy—Results of the First French Prospective Study for the French Society of Pediatric OncologyJournal of Clinical Oncology, 2003
- Outcome of children with centrally reviewed low‐grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high‐grade glioma study CCG‐945Cancer, 2003
- Phase II Study of Carboplatin in Children With Progressive Low-Grade GliomasJournal of Clinical Oncology, 2002
- Visual pathway glioma: an erratic tumour with therapeutic dilemmasArchives of Disease in Childhood, 1997
- Incidence and neurodevelopmental outcome of periventricular hemorrhage and hydrocephalus in a regional population of very low birth weight infantsNeurosurgery, 1991
- Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An updateAnnals of Neurology, 1988